Mechanisms of resistance are complex and multifactorial, involving genetic and epigenetic alterations, pathway reactivation (such as MAPK and PI3K/AKT), metabolic rewiring, tumor microenvironment interactions, and immune escape. Here, AKT1 is linked to neoplasm.